Myocardial Infarction News and Research

RSS

Chronic heart failure (CHF) is common, deadly, disabling, costly but fortunately - treatable

During the last ten to 15 years, treatment of CHF has been dramatically improved by pharmacological therapy and devices. Treatment also has become more complicated.

5 Sep 2005

Vitamin B may do more harm than good in heart attack patients

Researchers from Norway have found that treating patients who have had a heart attack with high doses of B vitamins does not lower the risk of getting another heart attack or stroke. Contrary to expectations, B vitamins may do more harm than good.

5 Sep 2005

Heart failure patients are "a country" in Europe, there are so many

The number of hospitalizations for heart failure is about the same as for acute myocardial infarction. Our knowledge over acute heart failure patients treated at hospitals for heart failure is based on surveys. In Europe the information is still scarce but emerging especially through the European Society of Cardiology (ESC) Euroheart survey program.

5 Sep 2005

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure, according to an article in the September 14 issue of JAMA: The Journal of the American Medical Association.

5 Sep 2005

Viagra fights heart and lung diseases

German researchers have reported on the impact of Viagra on pulmonary hypertension at the Frontiers of Vascular Medicine Conference at Monash University this week.

30 Aug 2005

Statins reduce heart attack deaths by 50%

According to a U.S. study, giving a heart attack patient a statin drug as soon as possible reduces the chance he or she will die by 50 percent.

30 Aug 2005

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

In the largest clinical study of its kind, UCLA researchers found that early treatment with a statin drug within 24 hours of having a heart attack reduced in-hospital mortality rates by over 50 percent.

29 Aug 2005

Continued race and sex disparities heart attack care

Differences based on race and sex in treatment patterns for hospitalized American heart attack patients have remained unchanged over an eight-year period, despite improvements in quality of heart attack care during this time, Emory and Yale School of Medicine researchers write in the August 18 issue of New England Journal of Medicine.

28 Aug 2005

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).

24 Aug 2005

Some medical conditions increase risk for developing major depression while others do not

Those who feel sad and lack an interest in regular life activities for at least two weeks and qualify for a diagnosis of minor depression are six times as likely to develop major depression compared to those who don't have these symptoms, according to a longitudinal study on risks for depression.

22 Aug 2005

Slower care for heart attack patients treated after hours and on weekends

Heart attack patients treated with primary percutaneous intervention (PCI) at hospitals after hours and on weekends wait longer to receive clot busters and other treatments and have a higher risk of death than those treated during regular hospital hours

18 Aug 2005

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.

17 Aug 2005

FDA approval for Diovan (Valsartan)

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.

4 Aug 2005

Stem cell therapy can be used effectively to treat heart attacks, or myocardial infarction, in pigs

In just two months, stem cells harvested from another pig's bone marrow and injected into the animal's damaged heart restored heart function and repaired damaged heart muscle by 50 percent to 75 percent.

25 Jul 2005

Evaluating how hospitals deliver medical care standardizes practices and improves care

In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia.

20 Jul 2005

Quality of care in U.S. hospitals

Ashish Jha, assistant professor of health policy and management at the Harvard School of Public Health and colleagues from Brigham and Women's Hospital and the Boston Veterans Affairs Healthcare System, have for the first time assessed the quality of care in U.S. hospitals.

20 Jul 2005

Insulin resistance increases a person's risk for development of congestive heart failure

Congestive heart failure (CHF) is a major cause of illness and death, according to background information in the article. The death rate for patients with CHF is 4 to 8 times that of the general population. The predominant causes of heart failure are hypertension and coronary heart disease.

19 Jul 2005

Myocardial Infarction News and Research

Chronic heart failure (CHF) is common, deadly, disabling, costly but fortunately - treatable

Vitamin B may do more harm than good in heart attack patients

Heart failure patients are "a country" in Europe, there are so many

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Viagra fights heart and lung diseases

Statins reduce heart attack deaths by 50%

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

Continued race and sex disparities heart attack care

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Some medical conditions increase risk for developing major depression while others do not

Slower care for heart attack patients treated after hours and on weekends

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

FDA approval for Diovan (Valsartan)

Stem cell therapy can be used effectively to treat heart attacks, or myocardial infarction, in pigs

Evaluating how hospitals deliver medical care standardizes practices and improves care

Quality of care in U.S. hospitals

Insulin resistance increases a person's risk for development of congestive heart failure

Abnormal heart rate variability is partially responsible for depression's effects in heart patients

Medicare's investment in quality improvement may not be paying off

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News